Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Sponsor
Saglik Bilimleri Universitesi (Other)
Overall Status
Recruiting
CT.gov ID
NCT05092568
Collaborator
(none)
45
1
2.3
19.3

Study Details

Study Description

Brief Summary

comparison of general characteristics of patients diagnosed COVID-19 positive followed In service

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    After the explanation about the study is made, informed consent form will be obtained from the pregnant women who were hospitalized in the pandemic gynecology service (D block 10th floor pandemic obstetrics service) due to COVID-19 and who agreed to participate in the study. In our study, the clinical status of pregnant patients with COVID-19 positive test results, who were followed up and treated in the pandemic service in Basaksehir City Hospital, will be obtained by asking the patient about the symptoms and vaccination status in the patient follow-up form prepared in advance. Laboratory findings and imaging results ( CT/ anteroposterior X-ray) will be obtained from the recorded data.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    45 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Comparison of General Characteristics of Patients Diagnosed COVID-19 Positive Followed In Service
    Actual Study Start Date :
    May 5, 2022
    Anticipated Primary Completion Date :
    Jul 15, 2022
    Anticipated Study Completion Date :
    Jul 15, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    covid pregnancy

    Pregnant patients with positive polymerase chain reaction assay COVID-19 test results, who were followed up and treated in the pandemic service of Başakşehir Çam and Sakura City Hospital.

    Outcome Measures

    Primary Outcome Measures

    1. Number of Participants [Two months]

      Number of Participants diagnosed of polymerase chain reaction assay Positive COVID-19 followed İn service

    2. Number of vaccinated participants [Two months]

      Vaccinated patients who were followed up in the service due to COVID-19

    3. Number of non-vaccinated Participants [Two months]

      non-vaccinated patients who were followed up in the service due to COVID-19

    4. rate of non-vaccinated -vaccinated Participants [Two months]

      rate of non-vaccinated- vaccinated Participants who were followed up in the service due to COVID-19

    5. rate of covid symptoms [Two months]

      rate of covid common symptoms (cough, fever, shortness of breath ,sore throat ) in vaccinated and unvaccinated patients

    6. rate of inflammatory parameters [Two months]

      rate of lymphocyte and albumin levels , C-reactive protein (CRP), D-dimer, Ferritin, lactate dehydrogenase(LDH), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and C-reactive protein albumin ratio (CAR) levels in vaccinated and unvaccinated patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria: Pregnant patients positive COVID-19 test results followed up and treated in the pandemic service of Çam and Sakura City Hospital.

    Exclusion Criteria: no exclusion criteria

    -

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Unit, Başakşehir City Hospital, Hamidiye School of Medicine, University of Health Sciences, Başaksehir İstanbul Turkey 34480

    Sponsors and Collaborators

    • Saglik Bilimleri Universitesi

    Investigators

    • Principal Investigator: Ozge Ozdemir, Saglik Bilimleri Universitesi

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sevim Özge Özdemir, Doctor, Saglik Bilimleri Universitesi
    ClinicalTrials.gov Identifier:
    NCT05092568
    Other Study ID Numbers:
    • COVID-19
    First Posted:
    Oct 25, 2021
    Last Update Posted:
    May 6, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sevim Özge Özdemir, Doctor, Saglik Bilimleri Universitesi
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 6, 2022